Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome

被引：40

作者：

Jeraj, L. ^{[1
]}

Jezovnik, M. K. ^{[2
]}

Poredos, P. ^{[1
]}

机构：

[1] Univ Med Ctr Ljubljana, Dept Vasc Dis, Ljubljana, Slovenia

[2] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

来源：

THROMBOSIS RESEARCH | 2017年 / 157卷

关键词：

DEEP VENOUS THROMBOSIS; ORAL ANTICOAGULANTS; VEIN THROMBOSIS;

D O I：

10.1016/j.thromres.2017.05.029

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：46 / 48

页数：3

共 15 条

[1]

Baglin T, 2012, J THROMB HAEMOST, V10, P1702, DOI [10.1111/j.1538-7836.2012.04662.x, 10.1111/j.1538-7836.2012.04806.x]

[2] Oral Rivaroxaban for Symptomatic Venous Thromboembolism. [J].

Bauersachs, Rupert ;

Berkowitz, Scott D. ;

Brenner, Benjamin ;

Buller, Harry R. ;

Decousus, Herve ;

Gallus, Alex S. ;

Lensing, Anthonie W. ;

Misselwitz, Frank ;

Prins, Martin H. ;

Raskob, Gary E. ;

Segers, Annelise ;

Verhamme, Peter ;

Wells, Phil ;

Agnelli, Giancarlo ;

Bounameaux, Henri ;

Cohen, Alexander ;

Davidson, Bruce L. ;

Piovella, Franco ;

Schellong, Sebastian .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) :2499-2510

[3] Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis A post-hoc analysis [J].

Cheung, Y. Whitney ;

Middeldorp, Saskia ;

Prins, Martin H. ;

Pap, Akos F. ;

Lensing, Anthonie W. A. ;

ten Cate-Hoek, Arina J. ;

Villalta, Sabina ;

Milan, Marta ;

Beyer-Westendorf, Jan ;

Verhamme, Peter ;

Bauersachs, Rupert M. ;

Prandoni, Paolo .

THROMBOSIS AND HAEMOSTASIS, 2016, 116 (04) :733-738

[4] Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study [J].

Chitsike, R. S. ;

Rodger, M. A. ;

Kovacs, M. J. ;

Betancourt, M. T. ;

Wells, P. S. ;

Anderson, D. R. ;

Chagnon, I. ;

Le Gal, G. ;

Solymoss, S. ;

Crowther, M. A. ;

Perrier, A. ;

White, R. H. ;

Vickars, L. M. ;

Ramsay, T. ;

Kahn, S. R. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) :2039-2044

[5] Phase III Trials of New Oral Anticoagulants in the Acute Treatment and Secondary Prevention of VTE: Comparison and Critique of Study Methodology and Results [J].

Cohen, Alexander T. ;

Imfeld, Stephan ;

Rider, Thomas .

ADVANCES IN THERAPY, 2014, 31 (05) :473-493

[6] Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran [J].

Ellinghaus, Peter ;

Perzborn, Elisabeth ;

Hauenschild, Peter ;

Gerdes, Christoph ;

Heitmeier, Stefan ;

Visser, Mayken ;

Summer, Holger ;

Laux, Volker .

THROMBOSIS RESEARCH, 2016, 142 :44-51

[7] Long-term Low-Molecular-Weight Heparin and the Post-Thrombotic Syndrome: A Systematic Review [J].

Hull, Russell D. ;

Liang, Jane ;

Townshend, Grace .

AMERICAN JOURNAL OF MEDICINE, 2011, 124 (08) :756-765

[8] Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis [J].

Kahn, Susan R. ;

Shrier, Ian ;

Julian, Jim A. ;

Ducruet, Thierry ;

Arsenault, Louise ;

Miron, Marie-Jose ;

Roussin, Andre ;

Desmarais, Sylvie ;

Joyal, France ;

Kassis, Jeannine ;

Solymoss, Susan ;

Desjardins, Louis ;

Lamping, Donna L. ;

Johri, Mira ;

Ginsberg, Jeffrey S. .

ANNALS OF INTERNAL MEDICINE, 2008, 149 (10) :698-U7

[9] The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies A Scientific Statement From the American Heart Association [J].

Kahn, Susan R. ;

Comerota, Anthony J. ;

Cushman, Mary ;

Evans, Natalie S. ;

Ginsberg, Jeffrey S. ;

Goldenberg, Neil A. ;

Gupta, Deepak K. ;

Prandoni, Paolo ;

Vedantham, Suresh ;

Walsh, M. Eileen ;

Weitz, Jeffrey I. .

CIRCULATION, 2014, 130 (18) :1636-1661

[10] Healthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants [J].

Prandoni, Paolo .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (03) :185-194

← 1 2 →